Wiley, Pediatric Blood & Cancer, 4(56), p. 560-567, 2010
DOI: 10.1002/pbc.22905
Full text: Download
Background. An adapted LMB 96 derived protocol for B-cell non-Hodgkin lymphoma (NHL) was implemented at the pediatric oncology unit of the Children Welfare Teaching Hospital in Baghdad (Iraq) from 2000 to present. The purpose was to evaluate the feasibility and efficacy of this intensive therapeutic regimen in a limited resource country. Methods. Patients